tiprankstipranks
Trending News
More News >
Chordia Therapeutics Inc. (JP:190A)
:190A
Japanese Market

Chordia Therapeutics Inc. (190A) Income Statement

Compare
2 Followers

Chordia Therapeutics Inc. Income Statement

Last quarter (Q3 2025), Chordia Therapeutics Inc.'s total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q3, Chordia Therapeutics Inc.'s net income was ¥-423.01M. See Chordia Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 0.00¥ 0.00¥ 2.50B¥ 0.00¥ 800.00M
Gross Profit
¥ -1.43B¥ -4.09M¥ 503.18M¥ -3.15M¥ 800.00M
Operating Expenses
¥ 364.47M¥ 1.80B¥ 2.28B¥ 1.84B¥ 1.39B
Depreciation and Amortization
¥ 2.70M¥ 4.09M¥ 6.04M¥ 3.15M¥ 700.00K
EBITDA
¥ -1.79B¥ -1.82B¥ 218.10M¥ -1.77B¥ -687.06M
Operating Income
¥ -1.79B¥ -1.80B¥ 212.06M¥ -1.84B¥ -587.67M
Other Income/Expenses
¥ 6.33M¥ -23.31M¥ 13.70M¥ 67.47M¥ 62.46M
Pretax Income
¥ -1.78B¥ -1.82B¥ 225.76M¥ -1.78B¥ -525.21M
Net Income
¥ -1.79B¥ -1.83B¥ 223.34M¥ -1.78B¥ -527.11M
Per Share Metrics
Basic EPS
¥ -26.03¥ -31.11¥ 3.96¥ -39.78¥ -15.08
Diluted EPS
¥ -26.03¥ -31.11¥ 3.96¥ -39.78¥ -15.08
Weighted Average Shares Outstanding
68.61M 58.73M 56.44M 44.72M 34.95M
Weighted Average Shares Outstanding (Diluted)
68.61M 58.73M 56.44M 44.72M 34.95M
Currency in JPY

Chordia Therapeutics Inc. Earnings and Revenue History